NOTCH2 and cancer: Considering the roles of Notch2 antagonism in preserving bone homeostasis along with anti-cancer activity of Notch inhibitors [63,64], it is reasonable that targeting Notch2 can be considered as a potential treatment regimen against malignancies and also protecting bone.